drugset / Trial / NCT02700685
Effect of Pycnogenol® on ADHD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This double blind, randomised controlled trial examines the effect of a commercially available nutritional supplement on behaviour of ADHD patients, as well as on their physical and psychiatric co-morbidities, and level of oxidative stress and immune activity, as compared to placebo and standard pharmaceutical treatment for ADHD.
Timeline
- Start
- 2017-09-01
- Primary completion
- 2020-11-20
- Completion
- 2020-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylphenidate | Small molecule | 20 mg | — |
| Comparator | Methylphenidate | Small molecule | 30 mg | — |